drugset / Trial / NCT04317300
Feasibility of Treatment for Vaping Cessation
NaSingle-groupOpen-labelTreatment
Summary
Researchers are gathering information on the feasibility of treating e-cigarette users with 12-weeks of varenicline (Chantix®) in assisting with stopping the use of e-cigarettes.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 1 mg | — |
Indications
No indication recorded.